UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM SD
Specialized Disclosure Report
Skyline Medical Inc.
(Exact name of registrant as specified in its charter)
Commission File Number: 000-54361
| Delaware | | 33-1007393 |
| (State or other jurisdiction of | | (I.R.S. Employer |
| incorporation or organization) | | Identification No.) |
| | | |
| 2915 Commers Drive, Suite 900 | | Eagan, Minnesota 55121 |
| (Address of principal executive offices) | | (Zip Code) |
Bob Myers 651-389-4800
(Registrant’s name and telephone number, including area code, of the person to contact
in connection with this report.)
Check the appropriate box to indicate the rule pursuant to which this form is being filed, and provide the period to which the information in this form applies:
x Rule 13p-1 under the Securities Exchange Act (17 CFR 240.13p-1) for the reporting period from January 1 to December 31, 2014.
Section 1 – Conflict Minerals Disclosure
Skyline Medical Inc. (“Skyline”, “we”, “our” or the “Company”) has evaluated its current product lines and determined that certain products we manufacture contain tin, tungsten, tantalum and/or gold (3TG), which are defined as “conflict minerals” by the United States Securities and Exchange Commission that are necessary to the functionality or production of our products. Accordingly, we are filing this disclosure along with a Conflict Minerals Report to disclose the measures we have taken to determine the origin of the conflict minerals used in our products.
Item 1.01 Conflict Minerals Disclosure
We undertook due diligence measures, including surveying our direct suppliers to try to determine the sources of these minerals, which we purchase through a complex supply chain.
Currently, we do not have sufficient information from our suppliers or other sources to determine the country of origin of the conflict minerals used in our products or identify the facilities used to process those conflict minerals. Therefore, we cannot exclude the possibility that some of these conflict minerals may have originated in the Democratic Republic of the Congo or an adjoining country and are not from recycled or scrap sources.
Item 1.02 Exhibit
A copy of the Company’s Conflict Minerals Report for the reporting period from January 1, 2014 to December 31, 2014 is provided as Exhibit 1.01 hereto and is publicly available at: www.skylinemedical.com under News and Media. The content of any website referred to in this Form SD is included for general information only and is not incorporated by reference in this Form SD.
Section 2 - Exhibits
Exhibit 1.01 – Conflict Minerals Report as required by Items 1.01 and 1.02 of this Form.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the duly authorized undersigned.
| Skyline Medical Inc. | |
| | | |
| | | |
| By:/ | s/Bob Myers | Date: June 1, 2015 |
| | | |
| Name: | Bob Myers | |
| Title: | Chief Financial Officer | |
